Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Castle Biosciences Inc 505 S. Friendswood Drive Suite 401 Friendswood TX 77546 USA

https://castlebiosciences.com Employees: 610 P: 866-788-9007

Description:

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Key Statistics

Overview:

Market Capitalization, $K 808,842
Enterprise Value, $K 710,002
Shares Outstanding, K 28,007
Annual Sales, $ 219,790 K
Annual Net Income, $ -57,470 K
Last Quarter Sales, $ 85,780 K
Last Quarter Net Income, $ 2,270 K
EBIT, $ 8,000 K
EBITDA, $ 14,840 K
60-Month Beta 0.99
% of Insider Shareholders 7.20%
% of Institutional Shareholders 92.60%
Float, K 25,990
% Float 92.80%
Short Volume Ratio 0.59

Growth:

1-Year Return 50.18%
3-Year Return -30.87%
5-Year Return 10.69%
5-Year Revenue Growth 864.41%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.08 on 11/04/24
Next Earnings Date N/A
Earnings Per Share ttm 0.20
EPS Growth vs. Prev Qtr -74.19%
EPS Growth vs. Prev Year 130.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CSTL Ratios

Ratio
Price/Earnings ttm 142.25
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 1.47%
Return-on-Assets % 1.27%
Profit Margin % -26.15%
Debt/Equity 0.02
Price/Sales 3.63
Price/Cash Flow N/A
Price/Book 1.81
Book Value/Share 15.75
Interest Coverage -5,736.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar